ConvaTec reportedly out of the running for KCI

ConvaTec has reportedly dropped its bid for Kinetic Concepts, a company that focuses on wound care, a source who declined to be named told Swedish daily Dagens Industri.

The source told the paper the bid had fallen through after a pharmaceutical firm that had agreed to buy one of KCI's units as part of the deal pulled out. "There was then a hole in the financing that they could not fill," the source said, as quoted by Reuters. ConvaTec is owned by private-equity firms Nordic Capital and Avista Capital Partners. A representative from Nordic Capital declined to comment on the news, according to Reuters.

Back in July, KCI agreed to go private in a deal with Apax Partners, the Canada Pension Plan Investment Board and the Public Sector Pension Investment Board. Under the deal, the three would buy KCI for $68.50 per share in cash in a transaction valued at $6.3 billion, including KCI's outstanding debt.

The following month, however, KCI received a higher takeover offer from ConvaTec, which reportedly had letters of support from Goldman Sachs Group and Jefferies Group.

KCI has gained 13% in New York trading since July 5, one day before reports of the talks with Apax and its partners surfaced, Bloomberg notes.

- get more from Reuters
- check out the Bloomberg report

Suggested Articles

BD will begin working with Babson Diagnostics to help bring its lab-quality device for collecting blood from capillaries into retail pharmacies.

The former CEO of the molecular testing company Foundation Medicine, Troy Cox, has been named chairman of the Swiss big data firm Sophia Genetics.

Researchers at MIT used a machine-learning algorithm to uncover the potent antibiotic properties hiding within an old small-molecule candidate.